-+ 0.00%
-+ 0.00%
-+ 0.00%

SUPERLUMINAL MEDICINES: ANNOUNCES OVERSUBSCRIBED $60 MLN SERIES B FINANCING TO ADVANCE LEAD PROGRAM IN RARE GENETIC FORMS OF OBESITY INTO CLINIC

路透·09/03/2026 10:01:48

登錄查看新聞詳情